FILE - In this Tuesday, Sept. 25, 2012 file photo, a protester wears glasses with the euro and dollar symbols painted on the lenses before protesting the conservative government's handling of the economic crisis and to demand fresh elections, in Madrid. Many had hoped that 2012 would be the year when the global economy finally regained its vigor, but the three largest economies: The United States, China and Japan struggled, while the 17 countries that use euro endured a third painful year in their financial crisis and slid into recession, and emerging economies slowed. (AP Photo/Paul White, File)
Watson Pharma changes name to Actavis Inc.
Published: 03:42:41 PM, Thu 24 January 2013 UTC
PARSIPPANY, N.J. (AP) — Watson Pharmaceuticals Inc. said Thursday it has changed its name to Actavis Inc. following its purchase of the Swiss drugmaker in October.
As part of the change, the company's New York Stock Exchange ticker symbol switched to "ACT" from "WPI."
Watson agreed to buy Actavis Group in April for about $5.6 billion. It completed the deal on Oct. 31 and announced the planned name change on that date. The new Actavis is the third-largest generic drug company in the world and has about $8 billion in annual revenue.
Actavis shares rose 86 cents to $86.59 in morning trading. The stock has risen 46.5 percent since rumors about Watson buying Actavis began to circulate in March. The shares have been trading at all-time highs for months, peaking at $91.47 in late December.
Tags:
watson pharmaceuticals inc., new york stock exchange, watson, actavis, actavis group, actavis inc., stock exchange, change, computer_internet, annual revenue, third-largest generic drug, generic drug, pharmaceutical industry, stock, company, morning trading, stock market, pharmacology, all-time highs, exchange ticker symbol, watson pharma changes, swiss drugmaker, new actavis, actavis shares
